About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2/3NCT04265105

Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults

Investigators will test the superiority of Superiority Trial of Fluticasone-Vilanterol as needed in mild asthma compared to standard of care

Lead sponsor: Royal College of Surgeons in Ireland - Medical University of Bahrain•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Royal College of Surgeons in Ireland - Medical University of Bahrain

single centre randomised control trial with the aim of comparing the superiority of effectiveness and safety of fluticasone-vilanterol versus usual care. In this study there is random allocation of participants to usual care (Any ICS or SABA combination) or fluticasone-vilanterol daily single dose for the relief of symptoms.

Age

21 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adults between the ages of 18 and 75 years old with a diagnosis of mild asthma attending the participating primary health care centres in Bahrain, being managed with usual care (SABA or ICS and SABA combination) and no other medications

Exclusion Criteria

•Health centre medical record or self-reported use of LABA, leukotriene receptor agonist, theophylline, anticholinergic agent, oral corticosteroids for regular maintenance therapy in 3 months before entry to the trial. \[NB. nasal corticosteroid is permitted

Related studies

RECRUITINGPhase 2

A Phase IIb Trial of LQ036 in Poorly Controlled Asthma

NCT07589439 · Asthma

Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational Investigation

NCT07011394 · Diagnosis, Inflammation, and more

RECRUITINGPhase 3

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

NCT06023589 · Asthma

RECRUITINGPhase 3

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

NCT06979323 · Asthma

RECRUITINGPhase 2

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

NCT07323654 · Eosinophilic Asthma

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 31, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2/PHASE3

Enrollment18

Start dateDec 2021

Last updatedMar 31, 2023

Condition

Locations shown

RCSI Bahrain

Al Muharraq, Busaiteen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 31, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions